MiNK Therapeutics, Inc.

8-K Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Other events Mar 27, 2026 8-K Director or officer change Mar 19, 2026 8-K Director or officer change Jan 2, 2026 8-K Results of operations (earnings release) Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement Jul 15, 2025 8-K Other events Jul 14, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release) Mar 18, 2025 8-K Amended charter or bylaws; Shareholder vote results Jan 21, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Oct 31, 2024 8-K Director or officer change Oct 18, 2024 8-K Delisting notice or listing-rule failure Sep 13, 2024 8-K Delisting notice or listing-rule failure Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Shareholder vote results Jun 17, 2024 8-K Entered a material agreement; Unregistered sale of equity May 16, 2024 8-K Results of operations (earnings release) May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Delisting notice or listing-rule failure Feb 29, 2024 8-K Entered a material agreement; Took on a direct financial obligation Feb 14, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Director or officer change Oct 17, 2023